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Introduction
Postoperative recovery after major surgery depends 
on various factors, such as adequate pain relief, 
nausea or vomiting and mobilization1. After surgery, 
77% of adult patients experience pain. Among 
them, around 80% experience moderate to severe 
pain2. The goal of postoperative pain relief is to 
achieve optimal analgesia, facilitating a speedy 
return to normal physiological organ function with 
minimal side effects. Adequacy of postoperative 
pain control is one of the most important factors in 
determining when a patient can be safely discharged 
from a surgical facility and has a major influence 
on the patient’s ability to resume their normal 
activities of daily living3. Acute pain can rapidly 
evolve into chronic pain, and the two should not 
be viewed as separate entities. Failure to achieve 
effective analgesia is a major predictive factor for 
the conversion of acute postoperative pain to chronic 
pain after various types of surgery.
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Summary
Adequacy of postoperative pain control is one of the most important factors in determining when a patient 
can be safely discharged from a surgical facility. Furthermore, it has a major influence on the patient’s 
ability to resume the normal activities of daily living. Tramadol is a weak opioid analgesic that acts mainly 
on μ-opioid receptor and has been proven to provide effective and safe analgesic to post-operative patients. 
Celecoxib (celebrex) is a highly selective COX-2 inhibitor. It belongs to nonsteroidal anti-inflammatory drugs 
(NSAIDs) group which reduces inflammation and pain while minimizing gastrointestinal adverse reaction. 
This selectivity feature makes celecoxib an attractive alternative to opioids for the control of postoperative 
pain. 
 The purpose of this study was to evaluate the effectiveness of oral celecoxib, in comparison with oral 
tramadol, in term of analgesic properties and the need for additional tablet acetaminophen as rescue pain 
reliever in patients undergoing elective gynecological operation. 
 A randomized, single-blinded study was conducted on 100 ASA I and II patients who were randomized 
into two groups: tramadol or celecoxib. Following major gynaecological surgery, all patients were given 
standard patient-controlled analgesia (PCA) regime with intravenous morphine. Patients either received oral 
tramadol 100 mg 8 hourly or oral celecoxib 200mg 12 hourly for analgesia 24 hours post operation. Tablet 
acetaminophen  was available as a rescue analgesic. Patients were monitored for pain according to Modified 
Pain Score, haemodynamic changes and side effects. They were evaluated at 24, 32, 40 and 48 hours post 
operation.  The mean pain score at 24, 32, 40 and 48 hours post operation were 0.86 ± 0.45, 0.68 ± 0.47, 
0.42 ± 0.50, and 0.14 ± 0.35 in celecoxib group and 0.92 ± 0.44, 0.78 ± 0.41, 0.46 ± 0.54 and 0.18 ± 0.39 in 
tramadol group respectively. There were no significant differences in the mean pain score and between the 
two groups at each point of assessment (p>0.05).  None of the patients requested for tablet acetaminophen. 
Patient satisfaction was similar in both study groups.
 This study indicates that oral celecoxib 200 mg 12 hourly is adequate and suitable to be used as an 
alternative to oral tramadol 100 mg 8 hourly in controlling pain 24 hours following major operation without 
the need for additional tablet acetaminophen.
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 The current armamentarium of analgesic drugs 
and techniques for the management of postoperative 
pain continues to grow at a rapid rate. Extensive 
use of opioids is associated with a variety of peri-
operative side effects, such as ventilatory depression, 
drowsiness and sedation, postoperative nausea and 
vomiting, pruritus, urinary retention, ileus and 
constipation that can delay discharge. Therefore, use 
of non-opioid analgesic techniques can lead to an 
improved quality of recovery for surgical patients4.
 Non-steroidal anti-inflammatory drugs 
(NSAIDs) are widely used for the treatment of 
pain and inflammation by inhibiting the formation 
of prostaglandins5. Tissue injury and inflammation 
are associated with the upregulation of prostanoid 
synthesis and an abnormally exaggerated response 
to painful stimuli, resulting in the pain condition5. 
Cyclooxygenase is the enzyme that catalyses the 
first two reactions of prostaglandin, leading to 
the formation of prostaglandin H26. Since COX-2 
inhibitors do not affect platelet function, a potential 
use of COX-2 inhibitors would be to alleviate 
pain and avoid narcotics which are associated with 
nausea and vomiting, without increasing the risk of 
postoperative bleeding7.
 Immunohistochemical investigation shows 
that cyclooxygenase is expressed in various 
reproductive tissues. In the uterus, COX is primarily 
localized to endometrial epithelium, fallopian tube, 
perivascular cells of blood vessels in endometrium 
and deciduas. COX-2 is clearly involved in many 
normal gynaecological processes and in the etiology 
of several gynaecological disorders. It is used in 
specific applications, including the treatment of 
acute and chronic gynaecological pain as well as 
post-operative pain8.
 Celecoxib is a highly-selective COX-2 inhibitor. 
It belongs to the nonsteroidal anti-inflammatory 
drugs (NSAIDs) group which reduces inflammation 
and pain while minimizing gastrointestinal adverse 
reaction9. Its half-life is 11 hours and therefore, the 
usual dosage is 200 mg twice a day10,11. The actual 
prevalence of side effects from NSAIDs is low and 
in the relief of postoperative pain, they are excellent 
analgesic. The majority of data regarding adverse 
effects of NSAIDs have arisen from its long-term use 
in chronic arthritis12.
 Apart from NSAIDs, tramadol is also a potent 
drug which can be used for post operative analgesia. 
Tramadol has been used in a number of European 
countries for many years and has been approved 
by the Food and Drug Administration (FDA) in the 
United States13. It is a weak opioid analgesic, acting 
mainly on μ opioids receptors but also has additional 
analgesic action through the inhibition of neuronal 
re-uptake of neurotransmitter 5-hydroxytryptamine 
and noradrenaline as well as stimulation of 5-
hydroxytryptamine release. Unlike conventional 
opioids, tramadol has not been associated with 
clinically significant respiratory depression5.
 The purpose of this study was to evaluate whether 
an analgesic dose of oral celecoxib is similar to 
oral tramadol in terms of analgesic properties, and 
whether supplement of tablet acetaminophen is 
required to control the pain. This study was also 
aimed to evaluate whether celecoxib can serve as an 
alternative analgesic in acute pain service (APS) 24 
hours after operation (24 to 48 hours post operation) 
in our community. 
Methodology
This is a randomized, single blinded, prospective 
study which was carried out from June 2005 until 
June 2006. A total number of 100 subjects who had 
undergone various major gynaecological operations 
were included in this study with equal number in 
celecoxib and tramadol group. Types of gynaecological 
operation include total abdominal hysterectomy 
with or without bilateral salpingo-oophorectomy, 
cystectomy and myomectomy. Inclusion criteria 
include age 18 – 55 years, weight > 25 kg but < 
100 kg and classification of American Society of 
Anaesthesiologist Physical Status I or II. Exclusion 
criteria include lactating mothers, pregnancy and 
renal or liver impairment identified after routine 
preoperative screening of blood biochemistry.
 This study has been approved by the Ethical 
Committee, International Islamic University Malaysia 
and Tengku Ampuan Afzan Hospital, Kuantan, 
Pahang.  Patients who fulfilled inclusion criteria 
were included in the study after obtaining informed 
consent. Patient-controlled analgesia morphine 
(PCAM) was given to all patients only within the 
first 24 post-operative hours. After 24 hours, closed-
envelope techniques were used to allocate patients 
randomly to receive either oral celecoxib 200mg 
twice daily or oral tramadol 100mg 3 times daily for 
postoperative analgesia.  Hence, all patients received 
at least 48 hours of APS14,15. All patients were 
encouraged to ambulate during this study.
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Protocol
The anaesthetic regimen was standardized for all 
patients16. Premedication with 7.5 mg midazolam 
orally was given the night and 2 hours before surgery. 
Three to four mg.kg-1 of thiopentone and 3 μg.kg-1 
fentanyl were given for induction of anaesthesia with 
non depolarizing muscle relaxant given once patient 
was under anaesthesia. Inhalational anaesthesia with 
O2, N20 and isoflurane was given, dosed to maintain 
a clinically adequate depth of anaesthesia. Patients 
were reversed with 1.0 mg atropine and 2.5 mg.kg-1 
neostigmine at the end of operation.
In Recovery Room
Loading dose of 0.1 mg.kg-1 IV morphine17 up to a 
maximum dose of 10 mg18 was administered by slow 
intravenous injection before starting the patient-
controlled analgesia (PCA). Morphine solutions 
were diluted as 1 mg.ml-1. The devices were set to 
deliver 1.0 mg IV bolus dose of morphine with 10 
minutes lockout time. No baseline infusion was 
given. Rescue intravenous bolus of 1.0 mg morphine 
was prepared as standby PCA morphine. Patients 
were instructed properly on the use of standard PCA 
machine. This PCA technique was continued until 24 
hours post operation.
 The patients were monitored using standard 
monitor in the recovery room for at least 30 minutes 
and supplemented with oxygen via face mask. 
Patients were evaluated at the end of 30 minutes 
before being discharged to the general ward. They 
were again evaluated in ward 24 hours prior to 
cessation of  PCA use. Patients were then started 
on either oral celecoxib 200mg twice daily or oral 
tramadol 100 mg 3 times daily19 and monitored at 24, 
32, 40 and 48 hours post operatively. Patients were 
encouraged to ambulate during this period. Tablet 
acetaminophen 500 mg were to be given for rescue 
analgesia. 
 The monitored parameters in this study were 
pain scores, patient satisfaction and the need for 
rescue (supplementary) analgesics (acetaminophen 
500 mg). Pain scores were monitored using modified 
pain score (0=no pain; 1=slight pain; 2=tolerable 
pain; 3=severe pain; 4=worst pain imaginable20) 
Side effects were also evaluated, such as nausea and 
vomiting, headache, dizziness, respiratory depression, 
dry mouth and bleeding tendencies. 
Statistical analysis
Power analysis was done at the design stage of 
the study. Sample size calculation revealed that 29 
patients per study group were required in order to 
achieve a significance level of 5% (α=0.05) and 
power of study of 80% (β=0.2). Assuming an overall 
20% dropout rate, a total sample size of 70 would be 
necessary. Thus, sample size of 100 (50 per group) 
was considered sufficient to answer the principal 
objective of the study. The data were analyzed using 
computer software SPSS version 12.0. P < 0.05 was 
considered as statistically significant. Comparison 
of parametric/continuous data presented as mean 
± SD (such as age, weight, height, and body mass 
index) were analyzed using independent t-test, while 
categorical data (such as ethnic groups, types of 
operation, patient satisfaction and the need for tab 
acetaminophen supplement) were analyzed using 
Pearson chi-square. All the categorical data were 
expressed as number and percentage (%). The pain 
score was analyzed using independent t-test and 
general linear model repeated measures. Results 
were presented as mean ± SD.
Results
Demographic Characteristics 
A total number of 100 female patients post major 
gynecological surgery who fulfilled inclusion criteria 
were included in this study after they consented. 
80% of the subjects were Malay, compared with 
17.0% Chinese and 3% Indians. This is in line with 
the racial representation in the East Coast community 
in Malaysia 21.
 There were no significant statistical differences 
in ethnic group, age, weight, height and body mass 
index between the two study groups (p>0.05). Table 1 
summarizes and compares the patient characteristics 
in term of ethnic group distribution, age, weight, 
height and body mass index.
Types of operation
There were no statistical differences in the types of 
major gynaecological operations between the two 
study groups (p>0.05). Table 2 summarizes and 
compares the types of different major gynecological 
operations in celecoxib and tramadol groups.
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Pain score
Figure 1 demonstrates mean pain scores at 24, 
32, 40 and 48 hours post operation in celecoxib 
and tramadol groups. There were no significant 
statistical differences in the pain scores at each point 
of assessment in both study groups (p>0.05). None 
of the patients in the study group required tablet 
acetaminophen for pain rescue.
Side effects
Both celecoxib and tramadol were well tolerated 
by the patients, with no refusal of medication and 
no episodes of nausea and vomiting, headache, 
dizziness, allergic reaction or episodes of bleeding 
requiring intervention within the study periods.
Patient Satisfaction
Table 3 summarized and compared patient satisfaction 
in both study groups. There was no statistical 
difference in patient satisfaction between the two 
study groups (p>0.05).
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Table 1: Distribution of subjects according to ethnic group, age, weight, height and body mass index in celecoxib 
and tramadol groups 
Parameters Celecoxib Tramadol p Value
  Group n = 50 (%) Group n = 50 (%)
Ethnic group
 Malay 40 (80) 40 (80)
 Chinese 9 (18) 8 (16) 0.822
 Indian 1 (2) 2 (4)  
Age (years) 39.1 ± 9.1 40.6 ± 10.1 0.437
Weight (kg) 58.0 ± 11.1 59.7 ± 11.7 0.462
Height (cm ) 158.4 ± 6.9 157.2 ± 9.1 0.460
Body Mass Index 23.0 ± 3.3 24.0 ± 3.2 0.109
Results are presented in n (%) and mean ± SD
Table 2: Types of gynecological operations in celecoxib and tramadol groups
Types of operation Celecoxib  Tramadol p Value
  Group n = 50 (%) Group n = 50 (%) 
TAHBSO 18 (36) 20 (40) 
Hysterectomy 9 (18) 6(12) 
    p = 0.825
Cystectomy 16 (32) 18 (36) 
Myomectomy 7 (14) 6 (12) 
Results are presented in n (%)
63
Discussion
Currents needs for improvement in postoperative 
pain management include (1) more effective relief 
of pain and suffering for all postoperative patients; 
(2) preventing and /or treating other postoperative 
symptoms (which may or may not be related to 
analgesic therapies) such as nausea, pruritus, 
sedation, and cognitive dysfunction; and (3) 
promoting recovery from surgery by preventing and/
or treating postoperative physiologic dysfunction 
such as atelectasis and ileus22.
 Non-selective NSAIDs are frequently used 
analgesics for minor surgery and useful adjunctive 
analgesics in patients undergoing major surgery, 
decreasing pain and opioid requirements19. The 
introduction of a COX-2-specific inhibitor with 
analgesic properties could represent a significant 
therapeutic advance in the management of acute post-
operative pain. The recommended dose of celecoxib 
in acute pain is 200mg twice daily, and studies 
have shown that this dose has prolonged effect and 
produced effective analgesic effects.8 
 Since tramadol is available in oral form and is not 
widely used in our acute pain service, it was chosen 
in comparison with celecoxib, a commonly used 
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Figure 1: Mean post operative pain score at each duration of assessment in celecoxib and tramadol groups.
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Table 3: Patient satisfaction in celecoxib and tramadol groups
Patient satisfaction Celecoxib Group  Tramadol Group p Value
  n = 50 (%) n = 50 (%) 
Excellent 4 (8) 6 (12) 
Good  36 (72) 30(60) 
    p = 0.447
Satisfactory 10 (20) 14 (28) 
Poor  0 (0) 0 (12) 
Results are presented in n (%)
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analgesic in our hospital. We chose PCA as a post 
operative analgesic for the first 24 hours because of 
patient safety and to avoid bias from the health care 
personnel16. This study was conducted for 24 hours 
after we stopped PCA. This will give a total analgesic 
coverage of 48 hours since patients need 48 hours for 
complete control of pain postoperatively23,24. 
 Early assisted ambulation within 48 hours post 
surgery was recommended25. Keeping patient in 
bed longer than 2 days post-surgery can contribute 
to delayed functional recovery, delayed discharge 
and higher levels of dependency at discharge from 
acute care. In order to assist early ambulation, 
oral analgesic is a better choice of analgesic drug 
administration 24 hours after operation.
 Immobilized patients have deleterious effects on 
muscle, volume status, respiratory function, urinary 
tract, and skin integrity26. Patients who are obese or 
immobile are at risk of developing venous circulatory 
problems and predisposed to develop deep vein 
thrombosis. Early ambulation will significantly help 
to reduce deficits in venous blood flow by activating 
skeletal calf muscle pumps. It is also important 
to make optimum use of the respiratory system 
(respiratory pumps) to encourage specified breathing 
mechanism and to initiate collaborative skeletal and 
respiratory pump exercise. 
 All patients in both study groups were satisfied 
with the acute pain service given with none of them 
giving a poor response to both the analgesics. This 
suggests that oral celecoxib and tramadol were 
similar in terms of patient satisfaction with their 
analgesic coverage.  
 In our institution, the cost of oral analgesic is very 
much lower, compared to that of parenteral form, 
including PCA. The total cost for oral celecoxib 
per patient per day is RM 3.70 (USD 1.06) and RM 
3.90 (USD 1.11) for oral tramadol. In contrast, the 
use of PCA morphine 100 mg for 48 hours would 
cost the patient RM 11.80 (USD 3.40), without 
factoring in the cost of the accessories such as PCA 
pump, syringes, tubing and preparation. Therefore, 
these oral forms are cost-effective alternatives for 
post operative analgesia in our context of acute pain 
service.  
 Apart from that, there may be indirect cost 
savings from the elimination of opioid-induced side-
effects that may could increase nursing requirement 
and lead to delayed recovery. Murphy et al. in 199727 
reported that despite its conventional opioid structure 
and qualitatively similar pharmacological profile, 
tramadol has less effect on gastric motility, compared 
with opioids. Nausea, vomiting, headache and 
dizziness were not observed in our study. No patients 
in both groups developed allergic reactions during this 
study. There were no cutaneous manifestations due 
to histamine release such as mild flushing or urticaria 
over the hand at the site or cannula. The optimal non-
opioid analgesic technique for postoperative pain 
management would not only reduce pain scores and 
enhance patient satisfaction but also facilitate earlier 
mobilization and rehabilitation by reducing pain-
related complications after surgery. 
 In our study, we did not calculate the total usage 
of PCA morphine in each patient during the first 24 
hours post operation. This may contribute to bias 
as patients who had utilized more PCA morphine 
during the first 24 hours may have residual analgesic 
effects of morphine during the start of the study. 
Conclusion
Oral Celecoxib 200mg twice daily is as effective as 
oral Tramadol 100 mg 3 times daily in controlling post 
operative pain 24 hours after major gynaecological 
operation without the need for tablet acetaminophen 
500 mg supplement. 
Acknowledgements
This study received support from IRPA Prioritized 
Research Project No. IIUM 504 / 022 / 3 / LT 26 
for the Department of Anaesthesia and Critical 
Care, Kulliyyah of Medicine in Kuantan. We would 
like to express our appreciation to the Kulliyyah of 
Medicine and the Department of Anaesthesiology, 
Tengku Ampuan Afzan Hospital for their support.
References
1.  Raffa RB. Pharmacology of oral combination 
analgesics: rational therapy for pain. J Clin Pharm 
Ther 2001; 26: 257-262. 
2. McCrory CR., Lindahl SGE. Cyclooxygenase 
inhibition for postoperative analgesia. Anesth Analg 
2002; 95:169-76. 
3. Bardiau FM, Taviaux NF, Albert A, Boogaerts JG,  et 
al. An intervention study to enhance postoperative 
pain management. Anesth Analg 2003; 96: 179-85.
4. White PF. The changing role of non-opioid analgesic 
techniques in the management of postoperative pain. 
Anesth Analg 2005; 101:S5-S22.
Oral Analgesic 24 Hours After Major Operation
65
5. Joshi GP, White PF. Management of acute and 
postoperative pain. Curr Opin Anaesthesiol 2001; 14: 
417-421.
6. Samad T, Abdi S. Cyclooxygenase-2 and antagonists 
in pain management. Curr Opin Anaesthesiol  2001; 
14:527-532.
7. Gajraj NM. Cyclooxygenase-2 inhibitor. Anesth Analg 
2003; 96:1720-38. 
8. Houston AM, Teach SJ. COX-2 Inhibitor. Pediatr 
Emerg Care. 2004; 20: 396-401. 
9. Hayes EC, Rock JA. COX-2 inhibitors and their role 
in gynaecology. Obstet Gynecol Surv 2002; 57:768-
780.
10. Davis NM, McLachlan AJ, Day RO, Williams KM. 
Clinical Pharmacokinetics and Pharmacodynamics of 
Celecoxib: A selective Cyclo-Oxygenase-2 Inhibitor. 
Clin Pharmacokinet 2000; 38: 225-242.
11. Watcha MF, Issioui T, Klein KW, White PF. Cost 
and effectiveness of rafecoxib, celecoxib, and 
acetaminophen for preventing pain after ambulatory 
otolaryngologic surgery. Anaesth Analg 2003 Apr; 
96(4): 987-94.
12. Clement D, Goa KL. Celecoxib: a review of its use 
in osteoarthritis, rheumatoid arthritis and acute pain. 
Drugs 2000; 59: 957-80. 
13. Miller, R.D. Anaesthesia. Philadelphia: Churchill 
Livingstone. 1999; 5th edition.
14. Bloch MB, Dyer RA, Heijke SA and James MF. 
Tramadol infusion for postthoracotomy pain relief: 
A placebo-controlled comparison with epidural 
morphine. Anesth Analg 2002; 94: 523-528.
15. Pang WW, Mok MS, Lin CH, Yang TF, et al. 
Comparison of patient controlled analgesia (PCA) 
with tramadol or morphine. Can J Anaesth 1999; 46: 
1030-1035.
16. Wilder-Smith CH, Lauren H, Justin W and Lynnette 
D. Effects of morphine and Tramadol on somatic and 
visceral sensory function and gastrointestinal motility 
after abdominal surgery. Anesthesiology. 1999; 91: 
639-648.
17. Pang WW, Huang S, Tung CC and Huang MH. 
Patient-controlled analgesia with tramadol versus 
tramadol plus lysine acetyl salicylate. Anesth Analg 
2000; 91: 1226-9.
18. Silvasti M, Svartling N, Pitkanen M. and Rosenberg 
PH. Comparison of intravenous patient-controlled 
analgesia with tramadol versus morphine after 
microvascular breast reconstruction. Eur J Anaesthesiol 
2000; 17: 448-455.
19. le Roux,PJ, Coetzee JF. Tramadol today. Curr Opin 
Anaesthesiol 2000; 13: 457-461.
20. Chapman R, Casey KL, Dubner R, Foley KM, et al. 
Pain measurement: an overview. Pain 1985; 22: 1-31.
21. Malaysia Department of Statistics. (2000). Population 
distribution by local authority areas and mukims 
population and housing census 2000. Bibliographic 
formats for citing electronic information, [http://www.
statistics.gov.my /Bahasa/mediademo. htm].
22. Gilron I, Milne B, Hong M. Cyclooxygenase-
2 inhibitors in postoperative pain management. 
Anesthesiology 2003; 99: 1198-1208. 
23. Miaskowski C, Crews J, Ready LB, Paul SM., et al. 
Anesthesia-based pain service improves the quality of 
postoperative pain management. Pain 1999; 80: 23-29. 
24.  Singelyn FJ, Gouverneur JMA. Postoperative analgesia 
after total hip arthroplasty: IV PCA with morphine, 
patient controlled epidural analgesia, or continuous 
“3-in-1” block?: a prospective evaluation by our acute 
pain service in more than 1,300 patients. J Clin Anesth 
1999: 11: 550-554.
25. Siu AL, Penrod JD, Boockvar KS, Koval K, et al. 
Early ambulation after hip fracture. Arch Intern Med 
2005; 166: 766-771.
26. Oldmeadow LB, Edwards ER, Kimmel LA, Kipen E, 
et al. No rest for the wound: Early ambulation after 
hip surgery accelerates recovery. Aust N Z J Surg 
2006; 76: 607-611.
27. Murphy DB, Sutton A, Prescott LF, Murphy MB. A 
comparison of the effects of Tramadol and morphine 
on gastric emptying in man. Anaesthesia 1997; 52: 
1224-1229.
Oral Analgesic 24 Hours After Major Operation
